Long COVID risk found to be significantly lower following Omicron infection

The risk of developing long COVID is significantly lower following an infection with the Omicron variant than after an infection with earlier coronavirus variants.

Lilly’s Retevmo lands new accelerated approval for pediatric cancers

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 30, 2024

Unraveling the logic of genes with Boolean network models

Over the last 20 years, researchers in biology and medicine have created Boolean network models to simulate complex systems and find solutions, including new treatments

January 23, 2024

Close a regulatory loophole in the ACA to provide vaccine access for all Americans

The Patient Protection and Affordable Care Act, (generally known as the ACA), was signed into law in 2010. It expanded access to affordable, quality health

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.